These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 226904)

  • 21. The effect of the opioid-benzodiazepine, tifluadom, on ingestive behaviors.
    Morley JE; Levine AS; Grace M; Kneip J; Zeugner H
    Eur J Pharmacol; 1983 Sep; 93(3-4):265-9. PubMed ID: 6315453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the opiate antagonists diprenorphine and naloxone and of selected opiate agonists on feeding behavior in guinea pigs.
    Billington CJ; Herman BH; Bartness TJ; Levine AS; Morley JE
    Life Sci; 1990; 46(2):147-54. PubMed ID: 2153888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
    Leander JD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC; Kattau RW; Leander JD
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of naltrexone and naloxone's possible agonistic actions in the dog.
    Wettstein JG; Martin WR
    Drug Alcohol Depend; 1985 Aug; 15(4):353-60. PubMed ID: 2865117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism.
    Young GA; Khazan N
    Neuropharmacology; 1984 Oct; 23(10):1161-5. PubMed ID: 6097833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dose ratio comparison of the interaction between morphine and cyclazocine with naloxone in rhesus monkeys on the shock titration task.
    Yaksh TL; Rudy TA
    Eur J Pharmacol; 1977 Nov; 46(2):83-92. PubMed ID: 412680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential protracted effects of morphine and ethylketocyclazocine challenges on EEG and behavior in the rat.
    Young GA; Khazan N
    Eur J Pharmacol; 1986 Jun; 125(2):265-71. PubMed ID: 3527723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of morphine, pentazocine and cyclazocine alone and in combination with naloxone on electric shock titration in the squirrel monkey.
    Dykstra LA
    J Pharmacol Exp Ther; 1979 Dec; 211(3):722-32. PubMed ID: 117098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine.
    Wood PL; Rackham A; Richard J
    Life Sci; 1981 May; 28(19):2119-25. PubMed ID: 6114371
    [No Abstract]   [Full Text] [Related]  

  • 32. Simple in vivo tests that differentiate prototype agonists at opiate receptors.
    Cowan A
    Life Sci; 1981 Apr; 28(14):1559-70. PubMed ID: 6264252
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.
    Snell D; Harris RA
    Psychopharmacology (Berl); 1982; 76(2):177-81. PubMed ID: 6281840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 35. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of morphine, naloxone, d,l-cyclazocine, and d-amphetamine on behaviour controlled by a schedule of interresponse time reinforcement.
    Adam-Carrière D; Merali Z; Stretch R
    Can J Physiol Pharmacol; 1978 Oct; 56(5):707-20. PubMed ID: 709412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion.
    Carr KD; Bonnet KA; Simon EJ
    Brain Res; 1982 Aug; 245(2):389-93. PubMed ID: 6289969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ethylketocyclazocine on behaviors in mice using multi-dimensional behavioral analyses.
    Ukai M; Kameyama T
    Pharmacol Biochem Behav; 1987 Sep; 28(1):43-6. PubMed ID: 2821561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voltage dependent changes in opiate inhibition of electrically-driven guinea pig ileum longitudinal muscle.
    Matos FF; Malone MH
    Proc West Pharmacol Soc; 1985; 28():151-2. PubMed ID: 2999807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.